A Personalized health care approach applied to a Phase IIb study of the glucokinase activator AZD1656. - Jesper Havsol; Eva Johnsson; Maria Leonsson-Zachrisson; Björn Carlsson; Christian Sonesson; Martin Karpefors (AMIA, 2012)

Quantifying the effect of weight reduction on progression to type II diabetes in high risk patients. - Jesper Havsol; Martin Karpefors; Therese Rosklint; Cecilia Karlsson (AMIA, 2014)

Short Text Topic Modeling to Identify Trends on Wearable Bio-Sensors in Different Media Type. - Juhee Bae; Jesper Havsol; Martin Karpefors; Alexander Karlsson; Gunnar Mathiason (ISCBI, 2018)

Assessment of Objectively Measured Physical Activity as an Independent Estimator of Functional Status in Clinical Trials. - Rubén Buendía; Halsey Lea; Bo Zhang; Jesper Havsol; Faisal M. Khan; Henrik Sillén; Glynn Dennis (EMBC, 2020)

Analysis of Use and Outcomes of the Balance Digital Disease Management Tool for Patients with Type 2 Diabetes. - Rubén Buendía; Jesper Havsol; Viktor Lundberg; Kevin Sooben; Magnus Jörnten-Karlsson; Elisabeth Nyman; Faisal M. Khan; Glynn Dennis (EMBC, 2021)

Home-based Digital Assessments with Applied Sentiment & Emotion AI Capture Improved Quality-of-life in Asthma Patients. - Bo Zhang; Rubén Buendía; Nicholas Iannoti; Emma Ramsden; Paul O'Regan; Jason Swift; Sarah Lockwood; David J. Jackson; Glynn Dennis; Lynn Hagger; Jesper Havsol (EMBC, 2021)